Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04474678Not ApplicableCompleted

Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")

Role: collaborator

NCT01398553Not ApplicableWithdrawn

Automated Versus Standard Physiotherapy for Upper Limb Rehabilitation in Patients With Acquired Brain Lesions

Role: lead

NCT02458794Not ApplicableUnknown

Crossover Study of the LMA SupremeTM vs Ambu-Aura GainTM

Role: collaborator

NCT01146587Not ApplicableSuspended

Comparative Study of GangTrainer GT1, Lokomat and Conventional Physiotherapy

Role: collaborator

All 4 trials loaded